Physician profile
James G Hoff
NPI 1043253693
$1,720.44
in general payments reported to CMS, 2019-2025
26 companies · $64.82 in 2025
The $64.82 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $513 · 2020: $130 · 2021: $163 · 2022: $190 · 2023: $345 · 2024: $316 · 2025: $64.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $725.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $193.12 | 2021-2025 | Ffrct |
| Astrazeneca Pharmaceuticals Lp | $178.67 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $137.50 | 2019-2023 | Lifevest |
| Abbott Laboratories | $130.52 | 2022-2024 | Mitraclip |
| Medtronic, INC. | $128.48 | 2024-2025 | Corevalve Evolut R, Affera Mapping System |
| Medtronic Vascular, INC. | $112.00 | 2019 | |
| Alnylam Pharmaceuticals INC. | $110.12 | 2019 | |
| Novartis Pharmaceuticals Corporation | $83.40 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $80.65 | 2022-2023 | Camzyos |
| Merck Sharp & Dohme LLC | $80.51 | 2022-2024 | Verquvo |
| Pfizer INC. | $68.13 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $63.53 | 2019-2024 | Xarelto |
| Cardiovascular Systems INC. | $52.32 | 2022 | |
| Boston Scientific Corporation | $48.59 | 2019-2024 | Watchman Flx |
| Terumo Medical Corporation | $44.61 | 2023 | Glidesheath Slender, Tr Band |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $29.08 | 2022 | |
| Acist Medical Systems, INC. | $24.54 | 2019 | |
| Cardiva Medical, INC. | $22.59 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Irhythm Technologies, INC. | $21.49 | 2021 | |
| Amgen INC. | $20.65 | 2019 | |
| Cvrx, INC. | $18.70 | 2024 | Barostim Neo System |
| Allergan, INC. | $17.67 | 2020 | |
| Smith+Nephew, INC. | $14.89 | 2019 | |
| Siemens Medical Solutions USA, INC. | $14.23 | 2023 | Artis Icono Biplane |
| Atricure, INC. | $13.48 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $10.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Hoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.